Priska Degiacomi
In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood
Jámbor C, Reul V, Schnider T, Degiacomi P, Metzner H, Korte W. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Anesthesia and analgesia 2009; 109:1023-8.
01.10.2009In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood
01.10.2009Anesthesia and analgesia 2009; 109:1023-8
Jámbor Csilla, Reul Viviane, Schnider Thomas, Degiacomi Priska, Metzner Hubert, Korte Wolfgang C
Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding
Korte W, Lange J, Devay J, Zoller N, Degiacomi P, Eder M, Kownacki E, Gabi K, Gähler A, Szadkowski C, Schnider T. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110:239-45.
01.02.2009Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding
01.02.2009Anesthesiology 2009; 110:239-45
Korte Wolfgang C, Lange Jochen, Devay Jan, Zoller Norbert, Degiacomi Priska, Eder Monika, Kownacki Edward, Gabi Konrad, Gähler Anita, Szadkowski Christine, Schnider Thomas